Robert Weinstein's Insider Trades & SAST Disclosures
Robert Weinstein's most recent trade in XWELL Inc was a trade of 30,825 Employee stock option (right to buy) done . Disclosure was reported to the exchange on Nov. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Weinstein.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
XWELL Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 30,825 | 30,825 | - | - | Employee stock option (right to buy) | |
|
PharmaCyte Biotech Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 38,009 | 38,009 | - | - | Stock Option (Right to Buy) | |
|
XWELL Inc
|
Robert Weinstein | Director | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 30 May 2023 | 25,000 | 156,485 (1%) | 0% | 0.2 | 6,175 | Common Stock |
|
XWELL Inc
|
Robert Weinstein | Director | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 26 May 2023 | 25,000 | 131,485 (0%) | 0% | 0.3 | 6,250 | Common Stock |
|
XWELL Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
|
Synaptogenix Inc
|
Robert Weinstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 16 Dec 2022 | 27,000 | 33,198 | - | 1.2 | 31,641 | Common Stock, par value $0.0001 per share |
|
Synaptogenix Inc
|
Robert Weinstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
|
XWELL Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 46,875 | 46,875 | - | - | Stock Option (right to buy) | |
|
XWELL Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 31,250 | 196,485 (1%) | 0% | 0 | Common Stock | |
|
XWELL Inc
|
Robert Weinstein | Director | Sale of securities on an exchange or to another person at price $ 1.56 per share. | 19 Jan 2022 | 45,000 | 120,235 (0%) | 0% | 1.6 | 70,236 | Common Stock |
|
XWELL Inc
|
Robert Weinstein | Director | Sale of securities on an exchange or to another person at price $ 1.43 per share. | 20 Oct 2021 | 63,000 | 165,235 (1%) | 0% | 1.4 | 90,210 | Common Stock |
|
XWELL Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 200,000 | 228,235 (1%) | 1% | 0 | Common Stock | |
|
Synaptogenix Inc
|
Robert Weinstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 60,000 | 60,198 | - | 0 | Common Stock, par value $0.0001 per share | |
|
XWELL Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 43,077 | 43,077 | - | - | Stock Option (right to buy) | |
|
XWELL Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 28,235 | 28,235 (0%) | 0% | 0 | Common Stock | |
|
XWELL Inc
|
Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2020 | 185,000 | 185,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges